Nu-Tek Biosciences, LLC
13.1.2026 15:00:00 CET | Globenewswire | Press release
Nu-Tek BioSciences Reinforces Global Supply Leadership with Halal Certification Renewal
Nu-Tek BioSciences Reinforces Global Supply Leadership with Halal Certification Renewal
- Renewal marks over a decade of Halal compliance, securing critical supply chains for biopharmaceutical growth markets through 2026 and beyond.
MINNETONKA, Minn., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Nu-Tek BioSciences, the industry leader in 100% animal-origin-free (AOF) peptones and yeast extracts, announced today that it has successfully renewed its Halal certification from The Islamic Food and Nutrition Council of America (IFANCA). This certification reinforces Nu-Tek’s decade-long standing as a trusted partner to the global pharmaceutical, biotechnology, and industrial fermentation sectors.
Halal certification is essential for materials distributed throughout the Middle East and Southeast Asia—markets currently facing heightened regulatory standards slated for 2026. By maintaining these rigorous standards, Nu-Tek provides its global partners with an ethically sourced, high-performance supply chain that is technically and culturally compliant with evolving international requirements.
“We strive to be the partner that understands both the complex science of raw materials and the specific nuances of our customers' regional market expectations,” said Tom Yezzi, CEO of Nu-Tek BioSciences. “Our sustained Halal designation enhances our ability to meet the expanding demand for compliant, animal-free ingredients in the world's fastest-growing biopharmaceutical hubs.”
As the industry shifts toward a more holistic view of raw material qualification, incorporating religious and ethical considerations alongside technical specifications, Nu-Tek remains at the forefront. This designation, paired with the company’s Kosher/Organic certifications, and proprietary Variability Reduction Program (VRP), underscores Nu-Tek’s commitment to providing the most predictable and accessible raw material solutions in the biopharmaceutical industry.
About Nu-Tek BioSciences
Nu-Tek BioSciences is the market leader in the development and manufacturing of high-quality, 100% animal-origin-free (AOF) peptones and protein hydrolysates. Headquartered in Minnetonka, Minnesota, the company operates a state-of-the-art, purpose-built manufacturing facility dedicated to producing superior raw materials for the biopharmaceutical industry. Nu-Tek's innovative solutions are essential for cell culture and microbial fermentation, supporting the production of vaccines, therapeutics, and other vital biologics. More product information is available at www.nu-tekbiosciences.com.
Media Contact:
Courtney Jones
Director of Commercial Development
cjones@nu-tekbioscience.com
+1(952) 936.3614
www.nu-tekbiosciences.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4e540576-ddcd-4440-9264-e238409147b5
A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3db37752-2106-41c7-ad4a-dc17dc2e46e6

Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
North Media A/S18.8.2026 10:27:11 CEST | Pressemeddelelse
North Media offentliggør foreløbige resultater for 2. kvartal 2026 og justerer forventningerne til helåret
North Media A/S18.8.2026 10:27:11 CEST | Press release
North Media announces preliminary financial results for Q2 2026 and revises its full-year guidance for 2026
Sveriges Riksbank18.8.2026 10:15:00 CEST | Press release
RESULT OF RIKSBANK CERTIFICATE SALE
Spectra Defense Technologies18.8.2026 10:00:00 CEST | Press release
Spectra Opens New Oslo Facility to Scale In-Region Engineering and Production Capabilities
Statkraft AS18.8.2026 10:00:00 CEST | Press release
Statkraft modernises Vikfalli hydropower system
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom